首页> 外文期刊>生物医学研究杂志(英文版) >A germline variant N375S in MET and gastric cancer susceptibility in a Chinese population
【24h】

A germline variant N375S in MET and gastric cancer susceptibility in a Chinese population

机译:中国人群MET和胃癌易感性的生殖系N375S变异

获取原文
获取原文并翻译 | 示例
       

摘要

MET tyrosine kinase and its ligand,hepatocyte growth factor(HGF),play a pivotal role in the activties of tumor cells.A germline missense variant in exon 2 of the MET gene,N375S(rs33917957 A>G),may alter the binding affinity of MET for HGF and thus modify the risk of tumorigenesis.In this study,we performed a case-control study to assess the association between N375S and gastric cancer risk in 1,681 gastric cancer cases and 1,858 cancer-free controls.Logistic regression analysis was applied to estimate crude and adjusted odds ratios(ORs) and 95% confidence intervals(CIs) for the associations between genotypes and gastric cancer risk.We found that MET N375S variant genotypes(NS/SS) were associated with a significantly decreased risk of gastric cancer(OR = 0.78,95% CI = 0.63-0.96,P = 0.021) compared with the wildtype homozygote(NN).The finding indicates that this germline variant in MET may decrease gastric cancer susceptibility in Han Chinese.

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2012年第5期|315-318|共4页
  • 作者单位

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Medical Laboratory, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu 225001, China;

    Department of Gastroenterology, Yangzhou First People's Hospital, Yangzhou, Jiangsu 225009, China;

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Section of Clinical Epidemiology, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center,Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Section of Clinical Epidemiology, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center,Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Department of Epidemiology and Biostatistics, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210029, China;

    Medical Laboratory, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu 225001, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:48:01
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号